Related Experiment Video
Updated: Jan 4, 2026

An Automated Culture System for Use in Preclinical Testing of Host-Directed Therapies for Tuberculosis
Published on: August 16, 2021
Risk Factors for False-Negative Interferon-γ Release Assay Results in Culture-Confirmed Childhood TB
Mao-Shui Wang1,2, Xin-Jie Liu2
1Department of Lab Medicine, Shandong Provincial Chest Hospital, Jinan, China.
Insights
False-negative interferon-γ release assay (IGRA) results in childhood tuberculosis (TB) are linked to younger age, being overweight, and hypoproteinemia. These factors may delay diagnosis and treatment for pediatric TB patients.
Area of Science:
- Pediatric Infectious Diseases
- Clinical Diagnostics
- Tuberculosis Research
Background:
- Interferon-γ release assays (IGRAs) are crucial for diagnosing tuberculosis (TB).
- False-negative IGRA results in children can lead to delayed TB diagnosis and treatment.
- Risk factors for false-negative IGRA results in pediatric TB are not well understood.
Purpose of the Study:
- To identify risk factors associated with false-negative T-SPOT.TB results in children with confirmed TB.
- To improve the diagnostic accuracy of IGRA in pediatric TB cases.
Main Methods:
- Retrospective study of 156 culture-confirmed childhood TB patients who underwent T-SPOT.TB testing.
- Data collected via questionnaires included demographics and clinicopathological variables.
- Univariate and multivariate logistic regression analyses were used to identify risk factors.
Main Results:
- The T-SPOT.TB test had a positive rate of 85.9% in childhood TB patients.
- Multivariate analysis identified younger age (≤ 9 years), overweight (z-score > 0.37), and hypoproteinemia (total protein ≤ 68.4 g/L) as significant risk factors for false-negative results.
- These factors were associated with increased odds of false-negative IGRA results.
Conclusions:
- Younger age, being overweight, and hypoproteinemia are associated with false-negative T-SPOT.TB results in children.
- Healthcare professionals should consider these risk factors when interpreting IGRA results in suspected pediatric TB cases.
- This finding can help mitigate diagnostic delays in children with TB.
Abstract:
A negative interferon-γ release assay (IGRA) result might inappropriately lower the clinical suspicion for childhood tuberculosis (TB) and result in delayed treatment initiation. However, the risk factors associated with false-negative IGRA results in children remain unclear. Between May 2012 and January 2018, 156 culture-confirmed childhood TB patients who had received T-SPOT.TB test were included. Data, including demographic information and clinicopathological variables, were collected via questionnaires. Univariate and multivariate logistic regression analyses were performed to estimate the odds ratio (OR) and corresponding 95% CI of risk factors associated with false-negative T-SPOT.TB results. The positive rate of T-SPOT.TB test was 85.9% in childhood TB patients. Multivariate analysis revealed that younger age (≤ 9 years; OR = 4.782; 95% CI: 1.689, 13.539), weight for age (z-score > 0.37; OR = 4.256; 95% CI: 1.458, 12.428), and hypoproteinemia (total protein ≤ 68.4 g/L; OR = 7.131; 95% CI: 1.864, 27.271) were risk factors for false-negative T-SPOT.TB results in childhood TB. Younger age, overweight, and hypoproteinemia were found to be associated with false-negative T-SPOT.TB results in childhood TB. Health care professionals should consider these risk factors when evaluating suspected childhood TB with negative T-SPOT.TB results.
More Related Videos
15:57Application of Long-term cultured Interferon-γ Enzyme-linked Immunospot Assay for Assessing Effector and Memory T Cell Responses in Cattle
Published on: July 11, 2015
09:57System for Efficacy and Cytotoxicity Screening of Inhibitors Targeting Intracellular Mycobacterium tuberculosis
Published on: April 5, 2017
Related Concept Videos
Pulmonary Tuberculosis IV
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Pulmonary Tuberculosis I
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Pulmonary Tuberculosis III
The first classification is based on the development of the disease, and it includes the following categories:
Pulmonary Tuberculosis V
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
Pulmonary Tuberculosis II
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...